-
Devicemaker agrees to settle kickback allegations for estimated $18M — 5 details
Merit Medical Systems will pay an estimated $18 million to settle alleged False Claims Act violations, the devicemaker announced July 15. -
Amazon Business aims to lower supply spend for healthcare purchasers: 4 key insights
Small, local and nonprofit healthcare providers hurting from COVID-19-related losses can reduce their overall supply spend by reevaluating their procurement strategy, an Amazon Business spokesperson told Becker's ASC Review. -
Stryker's ASC-focused business: 3 things to know
Earlier this year, Stryker launched an ASC-focused business. -
Supply Chain Tip of the Week: Determine total joint replacement equipment and supply needs
Conversations with key stakeholders are critical to understanding what your immediate needs for implementing total joint replacements are. -
Why Compass ASCs are thriving after shutdowns — Testing, trust, inventory & more
Seven of Compass Surgical Partners' nine active ASCs met or exceeded volume expectations as of June 23, a feat following weekslong closures due to COVID-19, according to Stacy Danahy, RN, regional director of operations for the Raleigh, N.C.-based management company. -
5 more hand sanitizers may be toxic, FDA says
The FDA is warning against using five more hand sanitizers after they tested positive for menthol, according to a CNN report. -
3 Reasons ASCs Should Use a Single-Source Supplier
In today's cost-conscious, value-based healthcare system, demand for Ambulatory Surgery Centers (ASCs) continues to rise. -
CDC data on COVID-19 antibody testing: 4 things to know
Results from six antibody testing sites in the U.S. suggest that current COVID-19 case numbers reflect a severe undercount, according to CDC data released June 26. -
Labs warn of test result delays amid coronavirus surges
Commercial and clinical labs are warning that there may be extended turnaround times for COVID-19 test results amid an uptick in demand for testing as cases rise across the U.S. -
Company with no medical supply experience gets $2.4M contract to make surgical gowns
A company with no medical supply experience that was created by a former Pentagon official won a $2.4 million contract to supply the Bureau of Prisons with surgical gowns, ProPublica reported. -
9 brands of hand sanitizer may be toxic, FDA says
The FDA warned against using nine types of hand sanitizer, saying they may contain methanol, which is toxic when absorbed through the skin or ingested. -
WHO announces $18B plan to deliver 2B COVID-19 vaccines to high-risk populations
The World Health Organization announced a plan June 26 to purchase and deliver 2 billion doses of COVID-19 vaccines for high risk populations, STAT reported. -
Novartis pays DOJ, SEC $347M in kickback scheme settlement
Swiss pharma giant Novartis has agreed to pay $347 million to settle allegations of paying physicians overseas to use more of its products. -
SCA's Dr. Dan Murrey: How ASCs should approach COVID-19 testing, prepare for another surge
As the chief medical officer of Surgical Care Affiliates, Dan Murrey, MD, played an integral role in the company's response to the pandemic and subsequent resumption of elective surgery. -
Medline donating $1 million to racial equity groups
Medline is donating $250,000 to four organizations promoting "racial equity, social justice and access to education," the medical supply manufacturer and distributor announced June 16. -
Supply Chain Tip of the Week: Get physicians on board for total joint replacements
Procedures are shifting from inpatient to outpatient, and joint replacement is leading the way. Orthopedics are projected to grow 25% in the outpatient space over the next five years, and total joint replacement procedures are driving that growth with a projected 96% increase.1 -
Optum leads $26M funding round for digital therapeutics startup
Optum Ventures, the investment arm of UnitedHealth Group's Optum, led a recent $26 million funding round for smartphone-based chronic condition management startup Kaia Health. -
Strategic national stockpile back under HHS control
The U.S. government shifted control of the strategic national stockpile back to HHS after giving control to the Federal Emergency Management Agency in March, The Washington Post reported. -
5 drugmakers have recalled metformin products after FDA warning
Since the FDA said in late May that it found unacceptable levels of a caricinogen in metformin — the generic name for a drug commonly used to control blood pressure in Type 2 diabetes patients — five drugmakers have issued recalls of their metformin products. -
How ASCs are approaching COVID-19 testing
ASCs across the U.S. are figuring out how to approach COVID-19 testing of patients and staff at their centers.
Page 21 of 65